TAK Net Income Growth
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Net Income Growth
TAK Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported33.07%period ending
TAK TTM Net Income YoY % (-27.64% → 33.07%)
Year-over-year change
High-resolution chart · PNG
TAK net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 33.0668% | |
| 79.0692% | |
| -44.8485% | |
| -88.6102% | |
| -8.6993% | |
| -25.1161% | |
| 16.7468% | |
| 51.3344% | |
| -50.2585% | |
| -54.5554% | |
| -35.081% | |
| -10.1056% | |
| 52.6916% | |
| 37.7975% | |
| -37.3968% | |
| -54.9428% | |
| -54.2208% | |
| -38.8146% | |
| 142.769% | |
| 744.0617% | |
| 307.3173% | |
| 13,893.4872% | |
| 432.3783% | |
| 258.3365% | |
| 935.3873% | |
| -97.5377% | |
| -149.2193% | |
| -88.8857% | |
| -91.504% | |
| -41.6083% | |
| -41.9399% | |
| -13.8997% | |
| -24.883% | |
| 62.5944% | |
| 43.8583% | |
| 8.9132% | |
| 3.2835% | |
| 43.3793% | |
| 218.1622% | |
| 198.2025% | |
| 200.3344% | |
| 154.9919% | |
| -248.3675% | |
| -236.9074% | |
| -222.3086% | |
| -219.418% | |
| -36.4987% | |
| 33.9525% | |
| 73.7221% | |
| -6.9885% | |
| 15.8851% | |
| -23.0469% | |
| -46.5576% | |
| 5.7038% | |
| -46.9036% | |
| -54.7494% | |
| -47.5048% | |
| -49.9078% | |
| -24.0482% | |
| -5.1541% | |
| 4.0436% | |
| -16.7516% | |
| -21.8103% | |
| -28.3649% | |
| -27.6424% |